The productive forms of collaboration that were developed in the NGFN and the scientific impulses that emanate from the network form the basis for more than 1000 cooperation agreements with internationally-known universities and research institutions. The NGFN has partner institutes in almost all countries of the European Union, but also in the USA, Mexico, Israel, Cameroon, Togo, Bahrain, and many other countries.
Another advantage of the National Genome Research Network is the close interweaving of research and industry. The close collaboration between scientists from the genome research network and the economic sector is what enables the development of therapies and the production of drugs in a sufficient quantity and with a reliable quality. At an early stage the research groups participating in the NGFN sought to sign cooperation agreements with appropriate firms. The groups can list a number of small and mid-sized companies as well as large industrial corporations as partners:
- Abeta GmbH, Heidelberg
- Amersham -Biosciences Europe GmbH, Freiburg
- AnalytiCon Discovery GmbH, Potsdam
- Applied Biosystems Applera Deutschland GmbH, Überlingen
- Aventis Pharma, Paris, France
- Bio-Rad Laboratories GmbH, Munich
- Bitplane AG, Zürich, Switzerland
- Bruker Daltonik GmbH, Bremen
- Bruker Saxonia Analytik GmbH, Leipzig
- CONARIS Reserach Institute AG, Kiel
- CRAY Computer Deutschland GmbH, Munich
- DeveloGen AG, Göttingen
- Epidauros AG, Bernried
- Eppendorf AG, Hamburg
- Evotec OAI AG, Hamburg
- G2M Cancer Drugs AG, Frankfurt
- Galilei Software GmbH Munich
- GPC-Biotech AG, Martinsried near Munich
- Graffinity Pharmaceutical Design GmbH, Heidelberg
- IMGM Laboratories GmbH, Martinsried near Munich
- Ingenium Pharmaceutical AG, Martinsried near Munich
- IntegraGen S.A., Evry, France
- Labor für Medizinische Genetik, Martinsried near Munich
- Leica Mikroskopie und Systeme GmbH, Wetzlar
- Memorec-Stoffel GmbH, Cologne
- MoReData GmbH, Gießen
- Nikon GmbH, Düsseldorf
- Novartis Pharma, Basel, Switzerland
- Olympus Co. (Europa) GmbH, Hamburg
- Omicron GmbH, Taunusstein
- Orion Pharma GmbH, Espoo, Finland
- PE-Applied Biosystems GmbH, Weiterstadt
- PEPperPRINT, Heidelberg
- Perkin Elmer life sciences, USA
- phase-it intelligent solutions AG, Heidelberg
- Schering AG, Berlin
- Silicon Graphics, Mountain View, California, USA
- T.I.L.L. Photonics GmbH, Munich
- UCB Pharma, Brüssel, Belgium
- Xantos Biomedicine AG, Munich
- Carl Zeiss, Jena
